As of 30 September 2026, 4 Indian mutual funds hold Windlas Biotech Limited (Healthcare), led by UTI - Healthcare Fund at 1.42% of its net assets, per the AMCs' SEBI-mandated monthly disclosures.
As of 30 September 2026, 4 Indian mutual fund schemes disclose a holding in Windlas Biotech Limited (Healthcare). The table below lists every fund holding this stock along with its weight as a percentage of the fund's net assets (% to NAV), sorted from the highest conviction position downward.
Across the 4 funds holding Windlas Biotech Limited, the average position size is 0.69% of net assets. The highest-conviction holder is UTI - Healthcare Fund (Thematic), at 1.42%. Thematic funds account for 3 of the 4 holders, with the rest spread across 1 other category. Over the last month, 0 funds initiated a new position and 0 funds exited, with the largest weight change at UTI - Healthcare Fund (+0.14pp to 1.42%).
How funds changed their Windlas Biotech Limited position between their two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Fund | Weight | Change |
|---|---|---|
| UTI - Healthcare Fund | 1.28% → 1.42% | ▲ +0.14 |
| # | Fund | AMC | Category | % to NAV |
|---|---|---|---|---|
| 1 | UTI - Healthcare Fund | UTI Mutual Fund | Thematic | 1.42% |
| 2 | ICICI Prudential Pharma Healthcare and Diagnostics Fund | ICICI Prudential Mutual Fund | Thematic | 0.75% |
| 3 | ICICI Prudential Healthcare Fund | ICICI Prudential Mutual Fund | Thematic | 0.57% |
| 4 | Bandhan Small Cap Fund | Bandhan Mutual Fund | Equity | 0.03% |
Want to interpret these weights? Read How to Read a Mutual Fund's Monthly Portfolio Disclosure, or look up terms like % to NAV and conviction in the glossary.
Source: SEBI-mandated monthly portfolio disclosures by Indian AMCs. Percentages are of each fund's net assets on its latest disclosure date. For information only, not investment advice.